Carrier-Free Nanodrugs: From Bench to Bedside
ACS Nano · 03.09.2024 · 18 (35) · 23827-23841
DOI: 10.1021/acsnano.4c09027 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Nano, online erschienen am 20.08.2024. Verfasst von Fang Fang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and …. Hauptthemen laut MEDLINE: Nanoparticles. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 179 Literaturangaben. Gefördert von: National Medical Research Council, Ministry of Education - Singapore, National Research Foundation Singapore.
Abstract (Originalsprache)
Carrier-free nanodrugs with extraordinary active pharmaceutical ingredient (API) loading (even 100%), avoidable carrier-induced toxicity, and simple synthetic procedures are considered as one of the most promising candidates for disease theranostics. Substantial studies and the commercial success of "carrier-free" nanocrystals have demonstrated their strong clinical potential. However, their practical translations remain challenging and are impeded by unpredictable assembly processes, insufficient delivery efficiency, and an unclear in vivo fate. In this Perspective, we systematically outline the contemporary and emerging carrier-free nanodrugs based on diverse APIs, as well as highlight their opportunities and challenges in clinical translation. Looking ahead, further improvements in design and preparation, drug delivery, in vivo efficacy, and safety of carrier-free nanomedicines are essential to facilitate their translation from the bench to bedside.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, S…
- Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
- Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
- Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, 11 Biopolis Way, Helios, Singapore 138667, Singapore.
- Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.
ORCID-Profile: Xiaoyuan Chen
Förderung
- National Medical Research Council
- Ministry of Education - Singapore
- National Research Foundation Singapore
- National University of Singapore
Zitieren
APA
Fang, F., & Chen, X. (2024). Carrier-Free Nanodrugs: From Bench to Bedside. ACS Nano, 18(35), 23827-23841. https://doi.org/10.1021/acsnano.4c09027
Vancouver
Fang F, Chen X. Carrier-Free Nanodrugs: From Bench to Bedside. ACS Nano. 2024;18(35):23827-23841. doi:10.1021/acsnano.4c09027
BibTeX
@article{Fang2024,
author = {Fang, Fang and Chen, Xiaoyuan},
title = {Carrier-Free Nanodrugs: From Bench to Bedside},
journal = {ACS Nano},
year = {2024},
volume = {18},
number = {35},
pages = {23827--23841},
doi = {10.1021/acsnano.4c09027}
}
EUVIMED